Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN114195726B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel CuCl-catalyzed route offers cost reduction and scalable production for high-purity pharmaceutical intermediates without anhydrous conditions.